COMMUNIQUÉS West-GlobeNewswire

Novavax Appoints Rachel King to Board of Directors
01/11/2018
GAITHERSBURG, Md., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc., (Nasdaq: NVAX) today announced the appointment of Rachel King, Co-Founder and Chief Executive Officer of GlycoMimetics, Inc., to its Board of Directors [...]
IRIDEX Announces 2018 Third Quarter Financial Results and Raises Full Year 2018 Guidance
01/11/2018
MOUNTAIN VIEW, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- IRIDEX Corporation (Nasdaq: IRIX) today reported financial results for the third quarter and nine months ended September 29, 2018. Third Quarter Highlights Cyclo [...]
Geron Corporation Reports Third Quarter 2018 Financial Results and Recent Company Events
01/11/2018
Imetelstat program transition proceeding, including plans to initiate Phase 3 portion of IMerge Abstracts for IMbark and IMerge accepted for oral presentation at American Society of Hematology Meeting (ASH) in December [...]
Conatus Pharmaceuticals Reports Third Quarter 2018 Financial Results and Program Updates
01/11/2018
SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today [...]
Helius Medical Technologies to Present at the 12th Annual Canaccord Medical Technologies & Diagnostics Forum
01/11/2018
NEWTOWN, Pa., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that [...]
Portola Pharmaceuticals to Present New Interim Phase 2 Results for Cerdulatinib During an Oral Session at the 60th American Society of Hematology (ASH) Annual Meeting
01/11/2018
– Differentiated Syk/JAK Inhibitor Studied in Patients with Heavily Pre-Treated T-Cell Malignancies – – Also Accepted: Two Posters on Andexxa ® and an Oral Session on the Burden of Hospital Readmissions Due to Venous [...]
NewLink Genetics Reports Third Quarter 2018 Financial Results and Announces Abstracts to Be Presented at Upcoming Medical Meetings
01/11/2018
Management to Host Conference Call Today at 4:30 p.m. ET AMES, Iowa, Nov. 01, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the third quarter 2018 [...]
Tetraphase Pharmaceuticals to Host Third Quarter 2018 Financial Results Conference Call
01/11/2018
WATERTOWN, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening [...]
T2 Biosystems Reports Third Quarter 2018 Financial Results and Provides Corporate Update
01/11/2018
Quarterly Product Revenue Up 71% Year-Over-Year Reiterates 2018 Financial Guidance LEXINGTON, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the development and commercialization [...]
Allscripts announces third quarter 2018 results
01/11/2018
Reported third quarter growth of 16% in GAAP revenue to $522 million, 19% in non-GAAP revenue to $536 million Third quarter GAAP loss per share of $0.20, growth of 13% in non-GAAP EPS to $0.18 Year-to-date growth of 21 [...]
athenahealth Announces New Time For Third Quarter 2018 Earnings Release and Conference Call
01/11/2018
WATERTOWN, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that its third [...]
Retrophin Reports Third Quarter 2018 Financial Results
01/11/2018
Pivotal programs enrolling towards first data readout in 2019 Phase 2 study of CNSA-001 in PKU underway; top-line results expected in first half 2019 Completed offering of $276 million convertible senior notes due 2025 [...]
Adamas Reports Third Quarter 2018 Financial Results
01/11/2018
GOCOVRI™ (amantadine) extended release capsules sales increased to $10.6 million for the third quarter, with ~4,740 fulfilled prescriptions EMERYVILLE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, [...]
Align Technology SVP Chris Puco to Depart in March 2019
01/11/2018
SAN JOSE, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) today announced that Christopher C. Puco, senior vice president and managing director of the Americas region, has decided to [...]
IntelGenx to Report Third Quarter 2018 Financial Results on November 8, 2018 – Conference Call to Follow
01/11/2018
SAINT LAURENT, Quebec, Nov. 01, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its third quarter 2018 financial results after market close on [...]
Cytokinetics, Inc. Reports Third Quarter 2018 Financial Results
01/11/2018
METEORIC-HF Advancing to Trial Initiation FORTITUDE-ALS on Track to Complete Enrollment by Year End Phase 1 Clinical Studies of CK-274 and AMG 594 To Start in Q4 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]
Weekend Unlimited: Emerging Cannabis Lifestyle Brand -- CFN Media
01/11/2018
SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering [...]
Holding(s) in Company
01/11/2018
TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the [...]
Director/PDMR Shareholding
01/11/2018
Director/PDMR Shareholding November 1, 2018 – Shire plc (LSE: SHP, NASDAQ: SHPG) Notification of transactions by persons discharging managerial responsibilities 1. Details of the person discharging managerial [...]

Pages